The Times Australia
News From Asia

.

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc.

to launch and commercialise Libtayo® (cemiplimab), a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells, in South Korea and Taiwan.

Regeneron is a leading biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases. Libtayo® (cemiplimab) is currently approved for first-line monotherapy treatment of advanced non-small cell lung cancer (NSCLC), the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) and recurrent or metastatic cervical cancer in Korea. It is approved for monotherapy treatment of advanced NSCLC in Taiwan.

"We are excited to accelerate the availability of Libtayo® to patients in South Korea and Taiwan. With our proven track record and deep understanding of the complex biopharma environment in Asia, we are uniquely positioned to deliver innovative therapies to patients in the region. This also represents a significant milestone in our mission to make healthcare more accessible and improve patient outcomes, especially in the burgeoning oncology segment," said CEO of Zuellig Pharma, John Graham.

Libtayo®, which was invented using Regeneron's proprietary VelocImmune® technology, is currently approved by regulatory authorities in more than two dozen countries for various indications.
Hashtag: #ZuelligPharma #Regeneron #Oncology #Libtayo #Biotechnology #Healthcare #Pharmaceuticals



The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multibillion-dollar business covering 16 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

ZP Therapeutics, a division of Zuellig Pharma, is the commercialisation partner of choice for the healthcare industry with offices in 13 markets across Asia and over 2,500 associates. A catalyst in improving patient journeys and healthcare outcomes through commercial excellence, robust in-market capabilities and strong ethical principles, ZP Therapeutics is a trusted partner for expanding patient access and providing innovations to the healthcare community.

For more information, visit:

Times Magazine

Simplify Your Business With Advanced Payroll Services

Advanced payroll services are an invaluable tool for businesses of all sizes. They offer a comprehensive suite of payroll solutions that streamline the process of managing employee pay and taxes, while also providing employers with real-time data a...

Protected Trees in NSW: What You Need to Know

If you live in New South Wales, you might already have heard that some trees are protected by law. Maybe you discovered this when you contacted someone for a quote to remove them, or maybe you learned the hard way by getting a fine for removing a...

Types of EV Chargers

The world of electric vehicles is a confusing one, filled with abbreviations and acronyms that even the most seasoned EV drivers can't keep straight. It's also a rapidly changing landscape where cutting-edge technology is being developed at an in...

The Evolution Of TV Over The Years

If you have been around for long enough, you might have seen the tech evolution affecting life. This has significantly influenced the way we get entertained and stay busy. Gone are the days when kids would spend hours playing games in the backyar...

Credit Card Compare Australia on Major Rebuild and Relaunch

David Boyd's entrepreneurial journey is a compelling narrative of innovation, relentless pursuit of goals, and a firm belief in the transformative power of technology. He immigrated from Northern Ireland to Australia in 2003. Boyd became known as a...

Micke Lindebergh will be put on display across Mirvac’s retail centres

Shoppers at Mirvac retail centres are in for an exciting experience this spring, as vibrant and larger than-life artworks by the renowned artist Micke Lindebergh will be put on display across Mirvac’s  retail centres.  The display of Lindebergh’...